Shukra Pharmaceuticals standalone net profit rises 110.20% in the June 2025 quarter
Sales rise 69.50% to Rs 5.39 crore
Net profit of Shukra Pharmaceuticals rose 110.20% to Rs 1.03 crore in the quarter ended June 2025 as against Rs 0.49 crore during the previous quarter ended June 2024. Sales rose 69.50% to Rs 5.39 crore in the quarter ended June 2025 as against Rs 3.18 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales5.393.18 69 OPM %24.6825.79 -PBDT2.171.48 47 PBT1.380.81 70 NP1.030.49 110Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 13 2025 | 5:11 PM IST